Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study
Hypertension, a prevalent chronic disease, has been associated with increased COVID-19 severity. To promote the COVID-19 booster vaccination of hypertensive patients, this study investigated the willingness to receive boosters and the related influencing factors based on the health belief model (HBM...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Human Vaccines & Immunotherapeutics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2283315 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849472299593367552 |
|---|---|
| author | Ying Yan Qingyuan Chen Abudulimutailipu Nuermaimaiti Yingzi Xiao Le Chang Huimin Ji Huizhen Sun Qinggang Song Yuanfeng Gao Junjie Xu Lunan Wang |
| author_facet | Ying Yan Qingyuan Chen Abudulimutailipu Nuermaimaiti Yingzi Xiao Le Chang Huimin Ji Huizhen Sun Qinggang Song Yuanfeng Gao Junjie Xu Lunan Wang |
| author_sort | Ying Yan |
| collection | DOAJ |
| description | Hypertension, a prevalent chronic disease, has been associated with increased COVID-19 severity. To promote the COVID-19 booster vaccination of hypertensive patients, this study investigated the willingness to receive boosters and the related influencing factors based on the health belief model (HBM model). Between June and October 2022, 453 valid questionnaires were collected across three Chinese cities. The willingness to receive a booster vaccination was 72.2%. The main factors that influenced the willingness of patients with hypertension to receive a booster shot were male (χ2 = 7.008, p = .008), residence in rural (χ2 = 4.778, p = .029), being in employment (χ2 = 7.232, p = .007), taking no or less antihypertensive medication (χ2 = 9.372, p = .025), with less hypertension-related comorbidities (χ2 = 35.888, p < .0001), and did not have any other chronic diseases (χ2 = 28.476, p < .0001). Amid the evolving COVID-19 landscape, the willingness to receive annual booster vaccination was 59.4%, and employment status (χ2 = 10.058, p = .002), and presence of other chronic diseases (χ2 = 14.256, p < .0001) are associated with the willingness of annual booster vaccination. Respondents with higher perceived severity, perceived benefits, perceived self-efficacy, and lower perceived barriers were more willing to receive booster shots. The mean and median value of willingness to pay (WTP) for a dose of booster were 53.17 CNY and 28.31 CNY. Concerns regarding booster safety and the need for professional advice were prevalent. Our findings highlight the importance of promoting booster safety knowledge and health-related management among hypertensive individuals through professional organizations and medical specialists. |
| format | Article |
| id | doaj-art-ff3c5a22c9ba409182f63a2ae963f0f0 |
| institution | Kabale University |
| issn | 2164-5515 2164-554X |
| language | English |
| publishDate | 2023-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Human Vaccines & Immunotherapeutics |
| spelling | doaj-art-ff3c5a22c9ba409182f63a2ae963f0f02025-08-20T03:24:35ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2023-12-0119310.1080/21645515.2023.2283315Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional studyYing Yan0Qingyuan Chen1Abudulimutailipu Nuermaimaiti2Yingzi Xiao3Le Chang4Huimin Ji5Huizhen Sun6Qinggang Song7Yuanfeng Gao8Junjie Xu9Lunan Wang10National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing,P.R. ChinaThe First Clinical Medical College, Capital Medical University, Beijing, P.R. ChinaNational Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing,P.R. ChinaNational Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing,P.R. ChinaNational Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing,P.R. ChinaNational Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing,P.R. ChinaNational Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing,P.R. ChinaDepartment of Cardiology, Xi’an No.1 hospital, Xi’an, Shaanxi,P.R. ChinaHeart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing, P.R. ChinaClinical Research Academy, Peking University Shenzhen Hospital, Peking University, Shenzhen, Guangdong, P.R. ChinaNational Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing,P.R. ChinaHypertension, a prevalent chronic disease, has been associated with increased COVID-19 severity. To promote the COVID-19 booster vaccination of hypertensive patients, this study investigated the willingness to receive boosters and the related influencing factors based on the health belief model (HBM model). Between June and October 2022, 453 valid questionnaires were collected across three Chinese cities. The willingness to receive a booster vaccination was 72.2%. The main factors that influenced the willingness of patients with hypertension to receive a booster shot were male (χ2 = 7.008, p = .008), residence in rural (χ2 = 4.778, p = .029), being in employment (χ2 = 7.232, p = .007), taking no or less antihypertensive medication (χ2 = 9.372, p = .025), with less hypertension-related comorbidities (χ2 = 35.888, p < .0001), and did not have any other chronic diseases (χ2 = 28.476, p < .0001). Amid the evolving COVID-19 landscape, the willingness to receive annual booster vaccination was 59.4%, and employment status (χ2 = 10.058, p = .002), and presence of other chronic diseases (χ2 = 14.256, p < .0001) are associated with the willingness of annual booster vaccination. Respondents with higher perceived severity, perceived benefits, perceived self-efficacy, and lower perceived barriers were more willing to receive booster shots. The mean and median value of willingness to pay (WTP) for a dose of booster were 53.17 CNY and 28.31 CNY. Concerns regarding booster safety and the need for professional advice were prevalent. Our findings highlight the importance of promoting booster safety knowledge and health-related management among hypertensive individuals through professional organizations and medical specialists.https://www.tandfonline.com/doi/10.1080/21645515.2023.2283315HypertensionCOVID-19 boosterwillingnesshealth belief modelwillingness to pay |
| spellingShingle | Ying Yan Qingyuan Chen Abudulimutailipu Nuermaimaiti Yingzi Xiao Le Chang Huimin Ji Huizhen Sun Qinggang Song Yuanfeng Gao Junjie Xu Lunan Wang Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study Human Vaccines & Immunotherapeutics Hypertension COVID-19 booster willingness health belief model willingness to pay |
| title | Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study |
| title_full | Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study |
| title_fullStr | Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study |
| title_full_unstemmed | Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study |
| title_short | Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study |
| title_sort | acceptance of covid 19 boosters among hypertensive patients in china a multicenter cross sectional study |
| topic | Hypertension COVID-19 booster willingness health belief model willingness to pay |
| url | https://www.tandfonline.com/doi/10.1080/21645515.2023.2283315 |
| work_keys_str_mv | AT yingyan acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT qingyuanchen acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT abudulimutailipunuermaimaiti acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT yingzixiao acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT lechang acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT huiminji acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT huizhensun acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT qinggangsong acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT yuanfenggao acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT junjiexu acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy AT lunanwang acceptanceofcovid19boostersamonghypertensivepatientsinchinaamulticentercrosssectionalstudy |